Govt Sanctions Rs 181.59 Cr for Pharma Upgrades Under RPTUS, Parliament Informed
New Delhi: A total of 192 applications has been approved so far, with a total sanctioned amount of Rs 181.59 crore under the Government's Revamped Pharmaceuticals Technology Upgradation Scheme (RPTUS), the Ministry of Chemicals and Fertilizers informed the Parliament while outlining measures to strengthen the quality of Indian medicines exported abroad.
During a recent Rajya Sabha session, MP Shri Meda Raghunadha Reddy had asked whether the Government was aware of recent reports by the US Food and Drug Administration (FDA) uncovering lapses at factories run by major Indian pharmaceutical companies, including unsanitary manufacturing conditions, poorly trained staff, under-investigated complaints and evidence of contaminated drugs being exported to the US. He also sought details of the steps taken to ensure the quality of drugs exported abroad, the new Good Manufacturing Practices introduced under the Drugs and Cosmetics Rules to address such deficiencies, and the mechanisms put in place to ensure timely adoption of upgraded standards by all manufacturers.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.